[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353663-105":59,"doc-detail-353663-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","molecular-features-of-early-vs-late-onset-gastric-cancer-a-systematic-review-and-meta-analysis","Molecular features of early-vs.-late-onset gastric cancer - a systematic review and meta-analysis","","Early-onset gastric cancer (EOGC), diagnosed before age 50, shows distinct clinicopathological behavior, yet its molecular landscape is insufficiently defined. A systematic search of PubMed, Embase, and Web of Science compared molecular characteristics between EOGC and late-onset gastric cancer (LOGC). Meta-analyses evaluated TCGA molecular subtypes, gene mutations, therapeutic biomarkers, and serum tumor markers, estimating odds ratios with 95% confidence intervals.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/molecular-features-of-early-vs-late-onset-gastric-cancer-a-systematic-review-and-meta-analysis/353663/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/molecular-features-of-early-vs-late-onset-gastric-cancer-a-systematic-review-and-meta-analysis/353663.png","ImageObject",300,407,{"name":92,"@type":93},"Liam","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main research focus of this systematic review?","Question",{"text":112,"@type":113},"The review compares molecular characteristics of early-onset gastric cancer (EOGC) and late-onset gastric cancer (LOGC), using TCGA subtypes, gene mutations, therapeutic biomarkers, and serum tumor markers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were differences between EOGC and LOGC assessed?",{"text":117,"@type":113},"The study performed meta-analyses on eligible literature, calculating odds ratios with 95% confidence intervals and evaluating heterogeneity using the I² statistic.",{"name":119,"@type":110,"acceptedAnswer":120},"What molecular and biomarker differences were reported for EOGC?",{"text":121,"@type":113},"EOGC showed a higher prevalence of the genomically stable (GS) subtype and lower prevalence of the chromosomal instability (CIN) subtype, with more frequent CDH1 mutations and lower HER2, dMMR/MSI-H, p53 expression, and less frequent elevation of serum markers such as CEA and CA19-9.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},353663,1790812775,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":14,"preview_urls":145},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Lin etal. BMC Cancer (2026) 26:209 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-15567-5](https://doi.org/10.1186/s12885-026-15567-5)  \nSYSTEMATIC REVIEW Open Access  \nMolecular features of early-vs. late-onset  gastric cancer: a systematic review and metaanalysis  \nXinmei Lin 1,2,3†, Wenhan Shi 1,3†, Zitong Zhou4, Degang Li5*, Qiuyuan Yao5* and Yu Sun 1*  \nAbstract  \nBackground Early-onset gastric cancer (EOGC), diagnosed before age 50, is characterized by distinct clinicopathological features, though its molecular landscape remains poorly defined.  \nMethods A systematic literature search of PubMed, Embase, and Web of Science identified studies comparing molecular characteristics of EOGC and late-onset gastric cancer (LOGC) . Meta-analyses assessed differences in The Cancer Genome Atlas (TCGA) molecular subtypes, gene mutations, therapeutic biomarkers, and serum tumor markers. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated; heterogeneity was assessed using the I2 statistic.  \nResults EOGC was associated with a higher prevalence of the genomically stable (GS) subtype (OR = 1 . 71, 95% CI: 1.37–2. 12) and a lower prevalence of the chromosomal instability (CIN) subtype (OR = 0 . 62, 95% CI: 0 .50–0. 77) . CDH1 mutations were more frequent in EOGC (OR = 3 .44, 95% CI: 2 .85–4. 16), while HER2 expression (OR = 0 . 54, 95% CI: 0.43–0. 67), dMMR/MSI-H status (OR = 0 . 25, 95% CI: 0 .12–0. 53), and p53 expression (OR = 0 . 56, 95% CI: 0 .39–0. 82) were significantly lower. Serum markers including CEA and CA19-9 were also less frequently elevated in EOGC. Conclusion EOGC represents a biologically distinct subset of gastric cancer with unique genomic and immunological features. These findings support age-specific diagnostic approaches and emphasize the value of multiomic strategies to uncover the mechanisms driving early-onset disease.  \nKeywords Early-onset gastric cancer, TCGA classification, Gene mutations, Immune biomarkers, Molecular features, Meta-analysis  \n†Xinmei Lin and Wenhan Shi contributed equally to this work.  \n*Correspondence:  \nDegang Li[ldgido@163.com](ldgido@163.com)[ ](ldgido@163.com)Qiuyuan Yao [17677665976@163.com](17677665976@163.com)[ ](17677665976@163.com)Yu Sun [suny369@mail.sysu.edu.cn](suny369@mail.sysu.edu.cn)  \n1Digestive Diseases Center, The Seventh Affiliated Hospital, Sun Yat-Sen University, Shenzhen, Guangdong, China  \n2State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, SunYat-Sen University Cancer Center, Guangzhou, China  \n3School of Medicine, SunYat-Sen University, Shenzhen, Guangdong, China  \n4The Fifth Affiliated Hospital, Sun Yat-Sen University, Zhuhai, Guangdong, China  \n5Colorectal Surgery Division, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, Guangxi, China  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icens","cbCaikuKu4riDUC1","https://ap.wps.com/l/cbCaikuKu4riDUC1","pdf",2374017,12,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction\n## Global burden and age-related trends\n## Definition and clinical characteristics of EOGC\n## Molecular profiles and TCGA classification","[{\"question\":\"What is the main research focus of this systematic review?\",\"answer\":\"The review compares molecular characteristics of early-onset gastric cancer (EOGC) and late-onset gastric cancer (LOGC), using TCGA subtypes, gene mutations, therapeutic biomarkers, and serum tumor markers.\"},{\"question\":\"How were differences between EOGC and LOGC assessed?\",\"answer\":\"The study performed meta-analyses on eligible literature, calculating odds ratios with 95% confidence intervals and evaluating heterogeneity using the I² statistic.\"},{\"question\":\"What molecular and biomarker differences were reported for EOGC?\",\"answer\":\"EOGC showed a higher prevalence of the genomically stable (GS) subtype and lower prevalence of the chromosomal instability (CIN) subtype, with more frequent CDH1 mutations and lower HER2, dMMR/MSI-H, p53 expression, and less frequent elevation of serum markers such as CEA and CA19-9.\"}]","Molecular features of early-vs.-late-onset gastric cancer - a systematic review and meta-analysis | PDF",1790106614,[146,150],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/31f89499e59d886433aba0386a2b838b.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/d646bd13321a38c006508b94d35892af.webp",982,1309]